AUSCANN GROUP S
AUSCANN GROUP S
Share · AU000000AC89 · A2DLBP (XASX)
Overview
No Price
n/a
Company Profile for AUSCANN GROUP S Share
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.
Get up to date insights from finAgent about AUSCANN GROUP S

Company Data

Name AUSCANN GROUP S
Company AusCann Group Holdings Ltd
Website https://auscann.com.au
Primary Exchange XASX ASX
WKN A2DLBP
ISIN AU000000AC89
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Christopher Mews B. Bus,
Country Australia
Currency EUR
Employees 0,0 T
Address 35 Havelock Street, 6005 West Perth
IPO Date 2017-02-10

Ticker Symbols

Name Symbol
Over The Counter ACNNF
More Shares
Investors who hold AUSCANN GROUP S also have the following shares in their portfolio:
DR. MARTENS PLC  LS -,01
DR. MARTENS PLC LS -,01 Share
DT. BAHN FIN. 19/29 MTN
DT. BAHN FIN. 19/29 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025